Vincerx Pharma, Inc. financial data

Symbol
VINC on Nasdaq
Industry
Pharmaceutical Preparations
Location
260 Sheridan Avenue, Suite 400, Palo Alto, CA
Fiscal year end
December 31
Former names
Vincera Pharma, Inc. (to 1/5/2021), LifeSci Acquisition Corp. (to 12/22/2020)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 209 % -59.1%
Debt-to-equity 84.5 % +190%
Return On Equity -270 % -106%
Return On Assets -146 % -44.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.7M shares +38.8%
Common Stock, Shares, Outstanding 29.7M shares +38.8%
Entity Public Float 23M USD +16.2%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 38.3K shares +80.2%
Weighted Average Number of Shares Outstanding, Diluted 38.3K shares +80.2%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 11.9M USD -29.5%
Operating Income (Loss) -30M USD +47.8%
Nonoperating Income (Expense) 1.79M USD -41.6%
Net Income (Loss) Attributable to Parent -28.2M USD +48.1%
Earnings Per Share, Basic -1.29 USD/shares +49.6%
Earnings Per Share, Diluted -1.29 USD/shares +49.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.92M USD +18.6%
Marketable Securities, Current 8.4M USD -59.4%
Cash, Cash Equivalents, and Short-term Investments 20.8M USD
Other Assets, Current 334K USD -85.9%
Assets, Current 18.3M USD -42.5%
Property, Plant and Equipment, Net 98K USD -35.1%
Operating Lease, Right-of-Use Asset 1.69M USD -37%
Other Assets, Noncurrent 122K USD -80.4%
Assets 21.5M USD -39%
Accounts Payable, Current 1.54M USD -56.5%
Accrued Liabilities, Current 2.43M USD -43.4%
Liabilities, Current 5.33M USD -41.8%
Operating Lease, Liability, Noncurrent 697K USD -63.9%
Other Liabilities, Noncurrent 50K USD 0%
Liabilities 6.08M USD -45.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 24K USD -65.2%
Retained Earnings (Accumulated Deficit) -173M USD -18.1%
Stockholders' Equity Attributable to Parent 15.4M USD -36%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.5B USD
Liabilities and Equity 21.5M USD -39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.74M USD +40.9%
Net Cash Provided by (Used in) Financing Activities 5K USD +66.7%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 29.7M shares +38.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.66M USD -6.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.01M USD +18.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 37.7M USD +33.1%
Deferred Tax Assets, Gross 38.3M USD +32%
Operating Lease, Liability 1.93M USD -36.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -28.2M USD +48%
Lessee, Operating Lease, Liability, to be Paid 3.04M USD
Property, Plant and Equipment, Gross 256K USD 0%
Operating Lease, Liability, Current 1.24M USD +13.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.37M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.32M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 125K USD -62%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28K USD
Deferred Tax Assets, Operating Loss Carryforwards 15.5M USD +60.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 30M shares 0%
Unrecognized Tax Benefits 1.24M USD +26.5%
Operating Lease, Payments 1.3M USD +4.18%
Additional Paid in Capital 189M USD +10.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 13K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 2.53M USD -35.4%
Interest Expense 8K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%